Durham company secures whopping $175M to develop innovative drugs
A biotechnology company in Durham has closed a $175 million funding round to support its efforts to develop new ways of tackling major diseases. Tune Therapeutics last year hit a pivotal milestone of moving its first program into clinical trials. Now, the …